These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1893629)

  • 1. Circulatory antigen of Heymann nephritis. III. Presence of the 70-kD circulatory protein in the immune deposits of Heymann nephritis.
    Singh AK; Schwartz MM
    Clin Exp Immunol; 1991 Sep; 85(3):469-75. PubMed ID: 1893629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A major pathogenic antigen of Heymann nephritis is present exclusively in the renal proximal tubule brush border--studies with a monoclonal antibody against pronase-digested tubular antigen.
    Tsukada Y; Ono K; Maezawa A; Yano S; Naruse T
    Clin Exp Immunol; 1994 May; 96(2):303-10. PubMed ID: 8187338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic fate of monovalent and multivalent antibodies of Heymann nephritis following formation of surface immune complexes on glomerular epithelial cells.
    Singh AK; Kasinath BS
    Clin Exp Immunol; 1993 Dec; 94(3):403-11. PubMed ID: 8252800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of Heymann nephritis with a gp330/megalin fusion protein.
    Raychowdhury R; Zheng G; Brown D; McCluskey RT
    Am J Pathol; 1996 May; 148(5):1613-23. PubMed ID: 8623929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A small N-terminal 60-kD fragment of gp600 (megalin), the major autoantigen of active Heymann nephritis, can induce a full-blown disease.
    Oleinikov AV; Feliz BJ; Makker SP
    J Am Soc Nephrol; 2000 Jan; 11(1):57-64. PubMed ID: 10616840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial events in the formation of immune deposits in passive Heymann nephritis. gp330-anti-gp330 immune complexes form in epithelial coated pits and rapidly become attached to the glomerular basement membrane.
    Kerjaschki D; Miettinen A; Farquhar MG
    J Exp Med; 1987 Jul; 166(1):109-28. PubMed ID: 2885390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat.
    Schulze M; Baker PJ; Perkinson DT; Johnson RJ; Ochi RF; Stahl RA; Couser WG
    Kidney Int; 1989 Jan; 35(1):60-8. PubMed ID: 2651753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular development of immune deposits and proteinuria in Heymann nephritis.
    Kerjaschki D
    Clin Investig; 1993 Oct; 71(10):817-21. PubMed ID: 7508307
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolation of a 330-kDa glycoprotein from human kidney similar to the Heymann nephritis autoantigen (gp330).
    Kanalas JJ; Makker SP
    J Am Soc Nephrol; 1990 Nov; 1(5):792-8. PubMed ID: 2133428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis).
    Kerjaschki D; Neale TJ
    J Am Soc Nephrol; 1996 Dec; 7(12):2518-26. PubMed ID: 8989729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific uptake of Heymann's nephritic kidney eluate by rat kidney: studies in vivo and in isolated perfused kidneys.
    Neale TJ; Couser WG; Salant DJ; Lowenstein LM; Wilson CB
    Lab Invest; 1982 Apr; 46(4):450-3. PubMed ID: 7040800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of glomerular localization of subepithelial immune deposits: effects of altered antigen to antibody ratio, steroids, vasoactive amine antagonists, and aminonucleoside of puromycin on passive Heymann nephritis in rats.
    Salant DJ; Belok S; Stilmant MM; Darby C; Couser WG
    Lab Invest; 1979 Jul; 41(1):89-99. PubMed ID: 376941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
    Makker SP; Tramontano A
    J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term evolution of immune deposits in passive Heymann nephritis.
    Soares VA; Almeida DB
    Braz J Med Biol Res; 1992; 25(2):149-59. PubMed ID: 1339511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cellular pathology of Heyman nephritis: monoclonal antibodies against the pathogenic antigen Gp 330].
    Kerjaschki D
    Wien Klin Wochenschr; 1985 Jul; 97(14):581-8. PubMed ID: 3901534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of sequential glomerular eluates from rats with Heymann nephritis.
    Abrass CK
    J Immunol; 1986 Jul; 137(2):530-5. PubMed ID: 3487574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential localization of antibody to multiple regions of the glomerular capillary wall in passive Heymann nephritis.
    Rydel JJ; Schwartz MM; Singh AK
    Lab Invest; 1989 Apr; 60(4):492-8. PubMed ID: 2651800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolytic enzyme treatment reduces glomerular immune deposits and proteinuria in passive Heymann nephritis.
    Nakazawa M; Emancipator SN; Lamm ME
    J Exp Med; 1986 Dec; 164(6):1973-87. PubMed ID: 3537193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.